UPDATE 1-Merck drug Keytruda succeeds in late-stage esophageal cancer trial
November 14, 2018 at 07:15 AM EST
Merck & Co's blockbuster drug Keytruda met the main goal of a late-stage trial testing the treatment in patients with cancers of the digestive tract, the U.S. drugmaker said on Wednesday.
